These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15726102)
1. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Moss S; Thomas I; Evans A; Thomas B; Johns L; Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102 [TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance. Johns LE; Moss SM; J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944 [TBL] [Abstract][Full Text] [Related]
4. Mammography screening in the county of Fyn. November 1993-December 1999. Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252 [TBL] [Abstract][Full Text] [Related]
5. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144 [TBL] [Abstract][Full Text] [Related]
6. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099 [TBL] [Abstract][Full Text] [Related]
7. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. Moss S J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845 [TBL] [Abstract][Full Text] [Related]
8. False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial). Johns LE; Moss SM; Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2758-64. PubMed ID: 20837718 [TBL] [Abstract][Full Text] [Related]
9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088 [TBL] [Abstract][Full Text] [Related]
11. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme. Blanks RG; Wallis MG; Moss SM J Med Screen; 1998; 5(4):195-201. PubMed ID: 9934650 [TBL] [Abstract][Full Text] [Related]
12. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme. Young KC; Wallis MG; Blanks RG; Moss SM Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229 [TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Moss S; Waller M; Anderson TJ; Cuckle H; Br J Cancer; 2005 Mar; 92(5):955-60. PubMed ID: 15726103 [TBL] [Abstract][Full Text] [Related]
14. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768 [TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274 [TBL] [Abstract][Full Text] [Related]
16. Assessing the amount of unscheduled screening ("contamination") in the control arm of the UK "Age" Trial. Kingston N; Thomas I; Johns L; Moss S; Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1132-6. PubMed ID: 20233850 [TBL] [Abstract][Full Text] [Related]
17. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459 [TBL] [Abstract][Full Text] [Related]
18. Use of two view mammography compared with one view in the detection of small invasive cancers: further results from the National Health Service breast screening programme. Blanks RG; Moss SM; Wallis MG J Med Screen; 1997; 4(2):98-101. PubMed ID: 9275268 [TBL] [Abstract][Full Text] [Related]
19. Results from 10 years of breast screening in Wales. Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845 [TBL] [Abstract][Full Text] [Related]